This AI-powered genomics company is turning its attention to drug development
The next blockbuster drug could be developed with help from machine-learning techniques that are rapidly spreading from AI research to pharmacology labs. Deep Genomics, a Canadian company that uses machine learning to trace potential genetic causes for
2018-11-30
- READ MORE